Serological assessment of SARS-CoV-2 exposure in northern Sweden by the use of at-home sampling to meet geographical challenges in rural regions
Authors:
- Ebba RosendalEREbba Rosendal
- Julia WigrenJWJulia Wigren
- Remigius GroeningRGRemigius Groening
- Emma NilssonENEmma Nilsson
- Atin SharmaASAtin Sharma
- Akbar EspaillatAEAkbar Espaillat
- Leo HankeLHLeo Hanke
- Therese ThunbergTTTherese Thunberg
- Gerald McInerneyGMGerald McInerney
- Andrea PuharAPAndrea Puhar
- Felipe CavaFCFelipe Cava
Preprint
Abstract
The current SARS-CoV-2 pandemic has highlighted a need for easy and safe blood sampling in combination with accurate serological methodology. Venipuncture is usually performed by trained staff at health care centers. Long travel distances may introduce a bias of testing towards relatively large communities with close access to health care centers. Rural regions may thus be overlooked. Here, we demonstrate a sensitive method to measure antibodies to the S-protein of SARS-CoV-2. We adapted and optimized this assay for clinical use together with capillary blood sampling to meet the geographical challenges of serosurveillance. Finally, we tested remote at-home capillary blood sampling together with centralized assessment of S-specific IgG in a rural region of northern Scandinavia that encompasses 55,185 sq kilometers. We conclude that serological assessment from capillary blood sampling gives comparable results as analysis of venous blood. Importantly, at-home sampling enabled citizens living in remote rural areas access to centralized and sensitive laboratory antibody tests.Keywords
All Related Versions
- Published version: Eurosurveillance, 28 (13), 2200432.
This publication has 20 references indexed in Scilit:
- Not just antibodies: B cells and T cells mediate immunity to COVID-19Nature Reviews Immunology, 2020
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessmentNature Communications, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Serology assays to manage COVID-19Science, 2020
- Neutralizing Antibodies against SARS-CoV-2 and Other Human CoronavirusesTrends in Immunology, 2020
- COVID-19: in the footsteps of Ernest ShackletonThorax, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measuresJournal of Medical Virology, 2020
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020